FDA Investigator Richard E Needham

Richard E Needham has inspections in 12 countries as of 27 Oct 2023. Richard E Needham has collaborated with a combinined 3092 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

27 Oct 2023

Investigator Role:

FDA Investigator

Redica ID:

100006067

Country:

Japan, Taiwan, Turkey, Norway, United States of America, China, Singapore, Germany, India, Sweden, Finland

Co-Investigator(s):

Addam S Reynolds, Adetutu M Gidado, Alan P Kurtzberg, Alicia M Mozzachio, Amy L Singer, Amy M Cramer, Angela E Glenn, Ann L Demarco, Anna M Brannen, Arsen Karapetyan, Azza Talaat, Barbara Janine Breithaupt, Barbara Jwilimczyk Macri, Barbara M Frazier, Bijoy Panicker, Burnell M Henry, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Charanjeet Jassal, Charisse K Green, Charles M Edwards, Charles R Cote, RIC, Cheryl A Clausen, Chris A Sack, Christina A Miller, Christopher S Keating, Claire M Minden, Cody D Rickman, Daniel J Grabicki, Dawn L Wydner, Debra J Bennett, Dell S Moller, Dennis Cantellops Paite, Denti Back, Dinesh Kumar, Dipesh K Shah, Don H Bark, PhD, Dorothy J Denes, Douglas A Campbell, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Edward D Mcdonald, Eric M Mueller, PharmD, Farhana Khan, Felix Maldonado, Frederick Razzaghi, Gam S Zamil, George J Flynn, Geroge J Flynn, Gwyn G Dickinson, Helen Verdel, Ivis Lnegron Torres, James C Maclaughlin, James L Dunnie, Jr, Javier E Santos, Javier O Vega, Jeffery A Hangartner, Jeffrey A Sommers, Jeffrey D Meng, Jeffrey P Raimondi, Jessica L Pressley, John A Podsadowski, John D White, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Jose Martinez, Jr, Jose R Hernandez, Jose Velez, Joseph F Mcginnis, RPh, Joseph L Despins, PhD, Juanita P Versace, Justin A Boyd, Justine Tomasso, Karen E D'orazio, Katherine E Jacobitz, Kelli F Dobilas, Kenneth M Gordon, Kent C Faul, Kevin A Gonzalez, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Ko U Min, Kristen D Evans, Kristina J Donohue, Larry K Austin, Laurie B Frazier, Lawrence J Stringer, Linda F Murphy, Linda Thai, Lucas B Leake, Luella J Rossi, Luis A Dasta, Mamta Gautam Basak, PhD, Marcellinus D Dordunoo, Marea K Harmon, Maria C Shih, Maria Estrella, Marie F Morin, Mark P Prusak, Matthew B Casale, Michael A Charles, Michael Gurbarg, Michael R Goga, Michele L Obert, Michele Perry Williams, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy M Espinal, Nicholas A Violand, Nicholas L Paulin, Nicole E Knowlton, Noreen Muniz, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patrick C Klotzbuecher, Patty P Kaewussdangkul, Paul L Bellamy, Paul Mouris, Pratik S Upadhyay, DDC, Ramon A Hernandez, Raymond T Oji, Richard J Friedman, Richard Needman, Rita K Kabaso, Robert B Shibuya, MD, Robert C Coleman, Robert D Tollefsen, Robert J Martin, Rochelle L Cross, Rochelle L Massey, Russell J Glapion, Saied A Asbagh, Samina S Khan, Sandra A Hughes, Sangeeta M Khurana, PhD, Santos E Camara, Scott T Ballard, Sean R Marcsisin, Sixto M Mercado Rios, Sneha S Patel, Sony Mathews, Stephen J Koniers, Steven C Madzo, Susan F Laska, MS, Susan W Ting, Susanne M Richardson, MSc RAC ELS, Tamil Arasu, PhD, Tammy L Chavis, Ted L Anderson, Temar Q Williams, Teresa I Navas, Tomika L Bivens, Torrance J Slayton, Truong Xuan Nguyen (Andy), Unnee Ranjan, Vlada Matusovsky, Wayne T Smith, William V Millar, Xiaokuang Lai, PhD, Yasamin Ameri, Yvins Dezan, Yvonne C Mcknight, Zachary L Miller

Richard E Needham's Documents

Publish Date	Document Type	Title
October, 2003	FDA 483	Delta Synthetic Co. Ltd. - Form 483, 2003-10-29
February, 2002	EIR	Laxai Life Sciences Private Limited - EIR, 2002-02-22
August, 2001	EIR	Yoneyama Yakuhin Kogyo Co., Ltd. - EIR, 2001-10-13
October, 2000	FDA 483 Response	Buchler GmbH - Form 483R, 2001-01-03
October, 2003	EIR	Takeda Giken Service, Ltd. - EIR, 2003-12-11
September, 2002	EIR	Recipharm AB - EIR, 2002-09-26
August, 2002	FDA 483	Microbac Labs Inc - Form 483, 2002-08-29
August, 2001	FDA 483	Sunlit Fluo & Chemical Co., Ltd. - Form 483, 2001-08-15
April, 2004	FDA 483	Suzhou no. 4 Pharmaceutical Factory - Form 483, 2004-04-01
October, 2003	EIR	YUNG SHIN PHARM. IND. CO., LTD. - EIR, 2003-11-26
October, 2003	FDA 483 Response	Delta Synthetic Co. Ltd. - Form 483R, 2003-11-28
April, 2004	FDA 483 Response	Suzhou no. 4 Pharmaceutical Factory - Form 483R, 2004-05-03
October, 2003	FDA 483 Response	YUNG SHIN PHARM. IND. CO., LTD. - Form 483R, 2004-01-26
October, 2003	EIR	Delta Synthetic Co. Ltd. - EIR, 2003-11-18
March, 2002	FDA 483	DR. REDDY'S LABORATORIES, LTD. - Form 483, 2002-03-01
October, 2000	FDA 483 Response	VTT Chemical Technology - Form 483R, 2000-11-06
October, 2000	FDA 483	VTT Chemical Technology - Form 483, 2000-10-13
April, 2004	EIR	Suzhou no. 4 Pharmaceutical Factory - EIR, 2004-05-13
September, 2002	FDA 483	Recipharm AB - Form 483, 2002-09-26
October, 2000	FDA 483	BASF AS avd Sandefjord - Form 483, 2000-10-18
April, 2003	EIR	Kyowa Hakko Kirin Co., Ltd. - EIR, 2003-04-03
October, 2003	FDA 483	Takeda Giken Service, Ltd. - Form 483, 2003-10-17
February, 2002	FDA 483	Ilsan Iltas - Form 483, 2002-02-15
October, 2000	EIR	Buchler GmbH - EIR, 2000-10-25
August, 2001	FDA 483	Yoneyama Yakuhin Kogyo Co. Ltd. - Form 483, 2001-08-08
October, 2000	FDA 483	Buchler GmbH - Form 483, 2000-10-25
September, 2002	FDA 483	AstraZeneca AB - Form 483, 2002-09-23
October, 2003	FDA 483 Response	Takeda Giken Service, Ltd. - Form 483R, 2003-11-11
April, 2003	FDA 483	KAKEN Pharmaceutical Co., LTD - Form 483, 2003-04-10
August, 2001	EIR	SUNLIT FLUO & CHEMICAL CO., LTD. CHUNG-LI FACTORY - EIR, 2001-08-15
February, 2002	FDA 483 Response	Laxai Life Sciences Private Limited - Form 483R, 2002-04-18
September, 2002	EIR	AstraZeneca AB - EIR, 2002-09-23
August, 2001	EIR	NIPPON RIKA CO., LTD. - EIR, 2001-11-06
September, 2002	FDA 483 Response	Recipharm AB - Form 483R, 2002-10-24
April, 2003	FDA 483 Response	Kyowa Hakko Kirin Co., Ltd. - Form 483R, 2003-06-20
October, 2000	EIR	VTT Chemical Technology - EIR, 2000-10-13
March, 2002	FDA 483 Response	DR. REDDY'S LABORATORIES LIMITED - Form 483R, 2002-03-08
February, 2002	FDA 483	Dr. Reddy's Laboratories Ltd. - Form 483, 2002-02-22
February, 2002	EIR	DR. REDDY'S LABORATORIES LIMITED - EIR, 2002-02-22
March, 2002	EIR	DR. REDDY'S LABORATORIES LIMITED - EIR, 2002-04-11
September, 2002	FDA 483 Response	AstraZeneca AB - Form 483R, 2002-10-22

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more